These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 32725130)
1. Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro study. Cutolo M; Soldano S; Montagna P; Martinelli G; Tardito S; Corallo C; Giordano N; Tavilla P; Cozzani E; Parodi A; Sulli A; Pizzorni C; Patane M; Smith V; Paolino S Rheumatology (Oxford); 2020 Dec; 59(12):3927-3938. PubMed ID: 32725130 [TBL] [Abstract][Full Text] [Related]
2. The IκB kinase inhibitor ACHP strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis. Mia MM; Bank RA J Cell Mol Med; 2015 Dec; 19(12):2780-92. PubMed ID: 26337045 [TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex. Schafer PH; Truzzi F; Parton A; Wu L; Kosek J; Zhang LH; Horan G; Saltari A; Quadri M; Lotti R; Marconi A; Pincelli C Cell Signal; 2016 Jul; 28(7):753-63. PubMed ID: 26806620 [TBL] [Abstract][Full Text] [Related]
4. Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition. Fioretto BS; Rosa I; Tani A; Andreucci E; Romano E; Sgambati E; Manetti M Cells; 2024 Jun; 13(12):. PubMed ID: 38920695 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1β attenuates myofibroblast formation and extracellular matrix production in dermal and lung fibroblasts exposed to transforming growth factor-β1. Mia MM; Boersema M; Bank RA PLoS One; 2014; 9(3):e91559. PubMed ID: 24622053 [TBL] [Abstract][Full Text] [Related]
6. The pro-fibrotic properties of transforming growth factor on human fibroblasts are counteracted by caffeic acid by inhibiting myofibroblast formation and collagen synthesis. Mia MM; Bank RA Cell Tissue Res; 2016 Mar; 363(3):775-89. PubMed ID: 26453399 [TBL] [Abstract][Full Text] [Related]
7. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts. Cutolo M; Ruaro B; Montagna P; Brizzolara R; Stratta E; Trombetta AC; Scabini S; Tavilla PP; Parodi A; Corallo C; Giordano N; Paolino S; Pizzorni C; Sulli A; Smith V; Soldano S Arthritis Res Ther; 2018 May; 20(1):77. PubMed ID: 29720235 [TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. Yang M; Huang H; Li J; Li D; Wang H FASEB J; 2004 Dec; 18(15):1920-1. PubMed ID: 15469966 [TBL] [Abstract][Full Text] [Related]
9. αII-spectrin and βII-spectrin do not affect TGFβ1-induced myofibroblast differentiation. Piersma B; Wouters OY; Bank RA Cell Tissue Res; 2018 Oct; 374(1):165-175. PubMed ID: 29725768 [TBL] [Abstract][Full Text] [Related]
11. Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts. Tannheimer SL; Wright CD; Salmon M Respir Res; 2012 Mar; 13(1):28. PubMed ID: 22452977 [TBL] [Abstract][Full Text] [Related]
12. Asthma-derived fibroblast to myofibroblast transition is enhanced in comparison to fibroblasts derived from non-asthmatic patients in 3D in vitro culture due to Smad2/3 signalling. Wnuk D; Lasota S; Paw M; Madeja Z; Michalik M Acta Biochim Pol; 2020 Nov; 67(4):441-448. PubMed ID: 33245228 [TBL] [Abstract][Full Text] [Related]
13. HMGB1 induces lung fibroblast to myofibroblast differentiation through NF‑κB‑mediated TGF‑β1 release. Wang Q; Wang J; Wang J; Hong S; Han F; Chen J; Chen G Mol Med Rep; 2017 May; 15(5):3062-3068. PubMed ID: 28339089 [TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 4 is overexpressed in human keloids and its inhibition reduces fibroblast activation and skin fibrosis. Milara J; Ribera P; Marín S; Montero P; Roger I; Tenor H; Cortijo J Chem Biol Interact; 2024 Oct; 402():111211. PubMed ID: 39197814 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of vitamin D and low concentration of transforming growth factor beta 1, a potential role in dermal wound healing. Ding J; Kwan P; Ma Z; Iwashina T; Wang J; Shankowsky HA; Tredget EE Burns; 2016 Sep; 42(6):1277-86. PubMed ID: 27222384 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages. Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of oxymatrine on TGF‑β1‑induced proliferation and abnormal differentiation in rat cardiac fibroblasts via the p38MAPK and ERK1/2 signaling pathways. Xu Y; Xiao H; Luo H; Chen Y; Zhang Y; Tao L; Jiang Y; Chen Y; Shen X Mol Med Rep; 2017 Oct; 16(4):5354-5362. PubMed ID: 28849213 [TBL] [Abstract][Full Text] [Related]
18. TRPV4 ion channel is a novel regulator of dermal myofibroblast differentiation. Sharma S; Goswami R; Merth M; Cohen J; Lei KY; Zhang DX; Rahaman SO Am J Physiol Cell Physiol; 2017 May; 312(5):C562-C572. PubMed ID: 28249987 [TBL] [Abstract][Full Text] [Related]
19. Substrate stiffness influences TGF-β1-induced differentiation of bronchial fibroblasts into myofibroblasts in airway remodeling. Shi Y; Dong Y; Duan Y; Jiang X; Chen C; Deng L Mol Med Rep; 2013 Feb; 7(2):419-24. PubMed ID: 23229284 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. Ramirez AM; Wongtrakool C; Welch T; Steinmeyer A; Zügel U; Roman J J Steroid Biochem Mol Biol; 2010 Feb; 118(3):142-50. PubMed ID: 19931390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]